Tag Archives: AZN

7 Stocks To Watch For May 18, 2018

Some of the stocks that may grab investor focus today are:

Wall Street expects Campbell Soup Company (NYSE: CPB) to report quarterly earnings at $0.61 per share on revenue of $2.14 billion before the opening bell. Campbell Soup shares fell 0.18 percent to $39.15 in after-hours trading.
Applied Materials, Inc. (NASDAQ: AMAT) reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Applied Materials shares fell 4.48 percent to $51.54 in the after-hours trading session.
Analysts are expecting Deere & Company (NYSE: DE) to have earned $3.29 per share on revenue of $9.83 billion in the latest quarter. Deere will release earnings before the markets open. Deere shares dropped 1.23 percent to $145.00 in after-hours trading.
AmTrust Financial Services Inc (NASDAQ: AFSI) shares rose over 5 percent in after-hours trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. AmTrust Financial shares climbed 5.81 percent to $14.21 in the after-hours trading session.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Analysts expect AstraZeneca plc (ADR) (NYSE: AZN) to report quarterly earnings at $0.35 per share on revenue of $5.24 billion before the opening bell. AstraZeneca shares declined 1.21 percent to $36.00 in after-hours trading.
Nordstrom, Inc. (NYSE: JWN) reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Nordstrom shares fell 7.03 percent to $47.33 in after-hours trading.
Boot Barn Holdings Inc (NYSE: BOOT) disclosed a 7.2 million common stock offering. Boot Barn shares dropped 3.14 percent to $23.72 in the after-hours trading session.

3 Top Penny Stocks to Watch in 2018

Investors searching for the top penny stocks to watch in 2018will want to take a close look at the three stocks we have on our list today, one of which is the top-performing penny stock of the year, with shares up 513.87% year to date.

But while penny stocks can bring triple-digit returns in a matter of weeks, they are also speculative investments that can see big pullbacks after making large gains.

For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.02. Investors who bought at $2.55 are sitting on a 60% loss today (Dec. 18).

Now that you know the risks and potential rewards, here are three of thetop penny stocksso far this year.

But for investors looking for a stock with future potential, we’ll also show you our pick for the best small-cap stock to own right now…

top penny stocks to watch in 2018moneymorning.com/wp-content/blogs.dir/1/files/2017/12/shutterstock_382043125-75×50.jpg 75w” sizes=”(max-width: 300px) 100vw, 300px” title=”top penny stocks to watch in 2018″ />Top Penny Stocks to Watch in 2018, No. 3: Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc.(Nasdaq: PIRS) is our other top-performing penny stockfor 2017.

This pharmaceutical company’s share price has skyrocketed 219.68% so far in 2017. PIRS shares are up 68.82% since May 1, which is when the company announced that it was entering a collaboration agreement with AstraZeneca Plc. (NYSE: AZN).

The new partnership is developing a treatment for respiratory disease. According to the agreement’s terms, PIRS will receive $45 million upfront and will work on an asthma treatment called PRS-060. Once that treatment goes into a phase 1 trial for asthma, PIRS will receive another $12.5 million payment from AstraZeneca.

Provided the treatments are successful, there is an additional $2.1 billion available for future milestones and royalties.

Shares of PIRS are currently trading at $6.01.

URGENT: The Night Trader Is Up to 908% Total Gains

Top Penny Stocks to Watch in 2018, No. 2: AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals Inc.(Nasdaq: AVEO) is another top performer to put on yourpenny stocks to watchlist.

The company’s share price has soared 468.5% so far this year, with 321.8% of those gains accumulating since June 23. On that date, AVEO received approval in Europe for its cancer drug called Tivozanib.

Tivozanib is a drug that treats advanced renal cell carcinoma, which is the fastest-growing type of kidney cancer. The drug failed to receive FDA approval in 2013, but it was recommended for European approval this summer. The drug’s phase 3 trial results are expected in Q1 2018.

AVEO is currently trading at $2.90 per share.

Top Penny Stocks to Watch in 2018, No. 1: Marinus Pharmaceuticals Inc.

The performance ofMarinus Pharmaceuticals Inc.(Nasdaq: MRNS) in 2017 is testament that you can certainly make money with penny stocks.

On June 30, MRNS shares traded for $1.37; today, they trade at $8.41, for a gain of 513.87% over little more than five months.

In fact, this pharmaceutical company’s share price is up 205.45% since Aug. 21 alone, which is the date that it announced successful clinical trials of its epilepsy treatment, Ganaxolone. The new drug treats the CDKL5 disorder, which is a rare, severe genetic form of epilepsy that results in early onset seizures and disabling behavioral issues.

In addition to CDLK5 disorder, MRNS plans to develop a treatment for patients suffering from Lennox-Gastaut syndrome (LGS), another severe form of epilepsy.

Shares of MRNS are currently trading at $8.41.

VideoMeet the Trading Expert Who Could Help Make You a Millionaire

Even though these biotech penny stocks have returned some explosive gains to their investors, we aren’t recommending them as stocks to buy now, since their gains are in the rearview mirror.

The true money to be earned lies in finding a stock that is poised for growth in a strong or resilient market. This is where Money MorningSmall-Cap Specialist Sid Riggs comes in.

Sid picked a company called Neurocrine Biosciences Inc. (Nasdaq: NBIX) in December 2013, while it was trading at a share price of $9. Since then, it has exploded to $74.43, for a 727% gain.

Sid’s pick today is also a medical company that has bested earnings estimates by an average of 40.5% since Q4 2016.

This company was the first to create an at-home HIV test kit. This gives it a competitive edge in the testing sector, which is forecast for 56.7% growth, from $2.17 billion in 2016 to $3.4 billion, within the next three years.

Here is Sid’s pick for the best medical small-cap stock to own in the coming year…

The Best Medical Small-Cap Stock to Own Now

Join the conversation. Click here to jump to comments…

3.3: This One Tiny Number Can Double Your Money

Michael A. RobinsonMichael A. Robinson

Let’s talk about a tiny number.

The sort of number that doesn’t show up on anyone’s radar.

Except mine.

And now yours.

I’m talking about a tech sector whose overall sales grew 3.3% in the third quarter. True, that sounds meaningless – like something you wouldn’t want to invest in.

But I drilled down below the surface, and I found a lot of money to be made from this meager bounce.

Here’s the thing. It’s a small tick on the information technology (IT) services sector’s massive $3.5 trillion base.

When I look closer, I see that most of that growth – billions and billions of dollars of growth – is thanks to global corporations and other huge enterprises moving their IT services to the cloud. Doing that allows them to cut back spending on computer networks and makes it easier to add new services on the fly.

And it gives tech investors a target-rich environment.

So while others ignore the billions of dollars moving around in this often-forgotten part of the tech ecosystem, let’s look at what I think will be a hugely profitable way to invest in this massive market.

It’s a company the mainstream financial media virtually ignores.

And it’s going to double your money in two years.

Here are five reasons why…

It’s Exciting… Really

You’d be hard pressed to find a quieter tech leader than ServiceNow Inc. (NYSE: NOW).

That’s likely because hardly anyone pays attention to IT services companies besides their customers. After all, the digital “plumbing” found in corporate campuses and skyscrapers is not as exciting as artificial intelligence, cryptocurrencies… or flying cars.

But what ServiceNow does – handling, processing, and automating IT requests – is absolutely crucial for any modern enterprise.

So consider this your opportunity to start paying attention – and making money.

While Wall Street doesn’t totally ignore the company – more than 30 industry analysts cover the stock – ServiceNow remains a largely unknown firm.

Sure, it’s nearly always stellar quarterly reports get covered. But over the last year or so, I’ve seen nary a standalone story about it in The Wall Street Journal, Investor’s Business Daily, or Bloomberg.

Meanwhile, ServiceNow has been steadily growing its profits per share much faster than even Amazon.com Inc. (Nasdaq: AMZN), the leader in cloud hosting.

ServiceNow is no slouch when it comes to sales. In the most recent quarter, it’s up 39.3% year over year. And ServiceNow’s execs forecast that sales will more than double from an estimated $1.9 billion this year to $4 billion by the end of 2020.

This Santa Clara, Calif., company has an impressive customer list. It works with everyone from healthcare giant AstraZeneca Plc. (NYSE: AZN) to chip leader Broadcom Ltd. (Nasdaq: AVGO) to consumer products titan Kimberly-Clark Corp. (NYSE: KMB).

Like I said, I think ServiceNow is poised – right now – to double your money in just two years.

To figure out why, let’s run it through the five “filters” of Your Tech Wealth Blueprint. These “rules” help us pinpoint the most exciting and fastest-moving opportunities so you can safely capture wealth – and have a better life now and in retirement.

Take a look…

Join the conversation. Click here to jump to comments…

Michael A. RobinsonMichael A. Robinson

About the Author

Browse Michael’s articles | View Michael’s research services

Michael A. Robinson is one of the top financial analysts working today. His book “Overdrawn: The Bailout of American Savings” was a prescient look at the anatomy of the nation’s S&L crisis, long before the word “bailout” became part of our daily lexicon. He’s a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies ones that have the power to sweep across the globe and change the very fabric of our lives and profit opportunities they give rise to. He also explores “what’s next” in the tech investing world at Strategic Tech Investor.

… Read full bio

3.3: This One Tiny Number Can Double Your Money

Michael A. RobinsonMichael A. Robinson

Let’s talk about a tiny number.

The sort of number that doesn’t show up on anyone’s radar.

Except mine.

And now yours.

I’m talking about a tech sector whose overall sales grew 3.3% in the third quarter. True, that sounds meaningless – like something you wouldn’t want to invest in.

But I drilled down below the surface, and I found a lot of money to be made from this meager bounce.

Here’s the thing. It’s a small tick on the information technology (IT) services sector’s massive $3.5 trillion base.

When I look closer, I see that most of that growth – billions and billions of dollars of growth – is thanks to global corporations and other huge enterprises moving their IT services to the cloud. Doing that allows them to cut back spending on computer networks and makes it easier to add new services on the fly.

And it gives tech investors a target-rich environment.

So while others ignore the billions of dollars moving around in this often-forgotten part of the tech ecosystem, let’s look at what I think will be a hugely profitable way to invest in this massive market.

It’s a company the mainstream financial media virtually ignores.

And it’s going to double your money in two years.

Here are five reasons why…

It’s Exciting… Really

You’d be hard pressed to find a quieter tech leader than ServiceNow Inc. (NYSE: NOW).

That’s likely because hardly anyone pays attention to IT services companies besides their customers. After all, the digital “plumbing” found in corporate campuses and skyscrapers is not as exciting as artificial intelligence, cryptocurrencies… or flying cars.

But what ServiceNow does – handling, processing, and automating IT requests – is absolutely crucial for any modern enterprise.

So consider this your opportunity to start paying attention – and making money.

While Wall Street doesn’t totally ignore the company – more than 30 industry analysts cover the stock – ServiceNow remains a largely unknown firm.

Sure, it’s nearly always stellar quarterly reports get covered. But over the last year or so, I’ve seen nary a standalone story about it in The Wall Street Journal, Investor’s Business Daily, or Bloomberg.

Meanwhile, ServiceNow has been steadily growing its profits per share much faster than even Amazon.com Inc. (Nasdaq: AMZN), the leader in cloud hosting.

ServiceNow is no slouch when it comes to sales. In the most recent quarter, it’s up 39.3% year over year. And ServiceNow’s execs forecast that sales will more than double from an estimated $1.9 billion this year to $4 billion by the end of 2020.

This Santa Clara, Calif., company has an impressive customer list. It works with everyone from healthcare giant AstraZeneca Plc. (NYSE: AZN) to chip leader Broadcom Ltd. (Nasdaq: AVGO) to consumer products titan Kimberly-Clark Corp. (NYSE: KMB).

Like I said, I think ServiceNow is poised – right now – to double your money in just two years.

To figure out why, let’s run it through the five “filters” of Your Tech Wealth Blueprint. These “rules” help us pinpoint the most exciting and fastest-moving opportunities so you can safely capture wealth – and have a better life now and in retirement.

Take a look…

Join the conversation. Click here to jump to comments…

Michael A. RobinsonMichael A. Robinson

About the Author

Browse Michael’s articles | View Michael’s research services

Michael A. Robinson is one of the top financial analysts working today. His book “Overdrawn: The Bailout of American Savings” was a prescient look at the anatomy of the nation’s S&L crisis, long before the word “bailout” became part of our daily lexicon. He’s a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies ones that have the power to sweep across the globe and change the very fabric of our lives and profit opportunities they give rise to. He also explores “what’s next” in the tech investing world at Strategic Tech Investor.

… Read full bio